<DOC>
	<DOCNO>NCT00532610</DOCNO>
	<brief_summary>This study assess change heart rhythm healthy volunteer take GSK189075 3 day normal dose high normal dose compare placebo single dose moxifloxacin . Treatments GSK189075 500mg daily three day plus moxifloxacin placebo Day 3 ; GSK189075 4000mg daily three day plus moxifloxacin placebo Day 3 ; placebo tablet daily three day plus moxifloxacin placebo Day 3 ; placebo tablet daily three day plus Moxifloxacin 400mg Day 3 . Volunteers blindfold dose . Each volunteer participate four treatment period receive dose combination study end . Volunteers stay research unit day first dose study drug day last dose study drug period . Safety measure include vital sign , laboratory test blood urine , physical exam ECGs . Volunteers wear Holter monitor ( device record heart rate rhythm continuously ) day 1 3 . Study drug level assess multiple blood draw , occur day 3 .</brief_summary>
	<brief_title>A Study Compare Effect Heart Rhythm 3 Days GSK189075 , Placebo , Moxifloxacin Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy male nonpregnant , nonlactating female 18 50 year age ( inclusive ) , time signing informed consent form . Body mass index ( BMI ) range 19 32 ( inclusive ) Healthy determine qualified physician basis satisfactory medical evaluation . Negative serum pregnancy test female subject . Subject give informed consent participate study indicate provide sign dated write informed consent form prior study procedure . The subject able understand comply protocol requirement , instruction protocolstated restriction . Cardiac conduction repolarization abnormality describe protocol . Any history myocardial infarction , syncope , cardiac arrhythmia history uncontrolled hypertension unstable heart disease . Subjects systolic blood pressure outside range 90 150mmHg diastolic blood pressure outside range 50 100mmHg , great than30mmHg change systolic blood pressure great 20mmHg change diastolic blood pressure upon orthostatic vital sign . Subjects personal family history QTc prolongation unexplained cardiac arrest . Liver function study ( ALT , AST , Total bilirubin , alkaline phosphatase 2 X upper limit normal reference range Screening Day 2 . Has history illicit drug use alcohol abuse within past year positive test alcohol , cotinine , drug abuse Screening prior start dose Period 1 . A history regular alcohol consumption average &gt; 7 drinks/week female &gt; 14 drinks/week male within 6 month Screening . Use tobacco nicotinecontaining product within 6 month prior Screening course study prohibit . A positive test Screening Hepatitis B , Hepatitis C , Human Immunodeficiency Virus ( HIV ) . If document negative test result obtain within last 2 month , necessary repeat test . Any abnormality K+ , Ca++ Mg++ TSH level outside normal range . Use prescription nonprescription drug , vitamin herbal dietary supplement within fourteen day 5 halflives ( whichever longer ) prior first dose study drug . Drugs known inhibit induce CYP3A4 enzymes restrict . Females childbearing potential unwilling unable use appropriate contraception define protocol . Pregnant nursing female . Females use oral contraception , implant levonorgestrel , injectable progesterone . Subjects whose participation study would result donation blood excess 500mL within 56 day period . History hypersensitivity GSK189075 , moxifloxacin , drug class , history drug allergy , opinion physician responsible , contraindicate participation . The subject receive investigational drug participate research trial within 30 day 5 halflives , twice duration biological effect drug ( whichever longer ) prior first dose current study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Diabetes ,</keyword>
	<keyword>ECG ,</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>GSK189075 ,</keyword>
</DOC>